chains at a limited number of sites along the polysaccharide chains3); the enzymes may be involved in the remodeling of the ECMand aid migration of cells such as macrophages4)
and tumor cells5). The endoglycosidases are also reported to be related to metastasis6), inflammation7) and angiogenesis8). However, more detailed investigation of the endoglycosidases has been limited due to the lack of cloned genes of the enzymes; it was only very recently that the relevant genes for the enzymes have been cloned from placenta, platelet and hepatoma cells9~n). Heparinase I, II and III cloned from Flavobacterium heparinumn\ are the other enzymes that degrade such HLG molecules that have been actively studied. These three enzymes are unique in their action since they cleave along the HLGs backbone with high degree of specificity13). In addition, heparinases were implicated in many growth factor-mediated cellular signaling14). There also were reports about the inhibition of the metastatic melanoma cells and other tumor cells by heparin and its derivatives15'16). Hence, heparinase inhibitors might provide useful tools for the elucidation of biological functions of heparin and HS and can be used as antimetastatic agents.
In the course of screening for heparinase inhibitors from microbial metabolite through a modified assay system for heparinase, we isolated novel inhibitors, CRM646-A (1) and -B (2) from Acremonium sp. MT70646 (Fig. 1) . In this communication, we report the fermentation, isolation, structural determination and biological activity of 1 and 2.
For the assay of heparinase activity, we measured the residual amount of heparin after the enzymereaction by a slight modification of conventional method. Briefly, 0.2 unit of heparinase (Sigma) was preincubated with test samples for 5 minutes and then enzymereaction was started by adding lO ng of porcine heparin (Sigma) in 25 /A ofa buffer (14mM sodium acetate and 1.4mM CaCl2, pH 7.0) for further 15 minutes at room temperature. For the measurementof the amount of heparin, the degree of complex formation between antithrombin and factor Xa was determined using the Sigma Diagnostics kit (Sigma Catalog No. CRS106-A), and then, the absorbance was measured on spectrophotometer at 405 nm.
The producing organism, Acremonium sp. MT70646 was isolated from a soil sample collected in Mt. Geryong, Kongju, in Korea. The seed culture was incubated in a medium consisting of 2.0% glucose, 0.5% Bactopeptone, 0.3% yeast extract, 0.3% malt extract, 0.05% MgSO4 and 0.1% KH2PO4at 26°C for 4 days on a rotary shaker (150rpm), and then transferred into a 15 liters jar fermentor containing 10 liters of the same medium. The production of 1 and 2 reached the maximum at 6 days culture. After the fermentation, an equivalent volume of acetone was added to 10 liters of culture broth and then the mixture was filtered. carboxyl group, and also the presence of -OH and C=C group were showed at 3397 cm"1, 2900 cm"1, respectively. The FAB-MSspectrum (in negative mode) of 1 gave a Fig. 2 . 'H-NMR spectrum ofCRM646-A (1) (300MHz, in DMSO-dF ig. 3. 13C-NMR spectrum ofCRM646-A (1) (75 MHz, in DMSO-d6).
Fig. 4. Significant correlations observed in the HMBCand NOESYspectra ofCRM646-A (1). molecular weight of 690 (mlz; 689 (M-H) ), whereas mlz 691 ((M-H)+)
was found in the positive FAB-MS spectrum. The molecular formula of 1 and 2 were determined to be C36H50O13 and C37H52O13 on the basis of HRFAB-MSand NMR data, respectively.
The 1H-and 13C-NMR spectra of 1 were shown in Fig. 2 and Fig. 3 indicated the presence of a sugar moiety. It was suggested that all of nine -CH2-carbons were originated from a saturated aliphatic chain. Therefore, it was confirmed that the aliphatic chain in 1 was consisted of fourteen -CH2 carbons and a terminal -CH3 (<5C 13.95).
In the HMBC spectrum of 1, the long-range coupling from H-8 (2H, <5H
1.26) to C-6 (8C 143.18), C-5 (Sc 108.31) and C-l (8C 113.53), from H-9 (2H, <5H 1.54) to C-6 suggested that the aliphatic chain was connected to C-6 carbon in ring A moiety. On the other hand, the structural elucidation of two substituted ring moieties was achieved through the HMBC and FAB-MS experiments. In fact, there are no correlations to connect two ring moieties as shown in Fig. 4 . But, because the molecular weight (mlz 167) of ring B moiety was showed in the FAB-MS spectrum, it could be concluded that the two ring moieties were connected with an ester bond between C-4' and C-7. Both H-3 (<5H 6.45) on ring A and H-3' (<5H 6.58) on ring B were showed correlations with the respective terminal carbonyl carbons at 8C 166.15 and 5C 170.55. The sugar moiety was determined as glucuronic acid by analyzing the coupling constants. In addition, the anomeric proton of H-l" was long-range coupled to C-4 (<5C 159.12) and C-5" (<SC 75.53) . From these data, it was confirmed that the C-1" carbon of glucuronic acid was linked to C-4 on ring A moiety. The stereochemistry at C-1" was elucidated to j5 by the l3C-lH coupling constant of C-1" (lJc_u=l6\2Hz). Thus, the structure of 1 was determined as shown in Fig. 1 . The !H-and 13C-NMRdata of2 were similar to those of 1 except the peak of one methoxy proton (<5H 3.66). In the HMBC spectrum, the methoxy proton showed a long-range coupling with C-6" carbon (<5C 169.14). Therefore, it was concluded that 2 was substituted with methoxy group at the position ofC-6" of1. The structure of 1 was similar to those of  known as the inhibitors of CAMP phosphodiesterase17).
However, there are clearly differences in the structures such as the sugar moiety (/?-D-glucose instead of glucuronic acid in 1), the length of aliphatic chain and the presence of carboxyl residue on the ring in the TPIs. Therefore, 1 and 2 are novel inhibitors for heparinase and this paper is a first report for heparinase inhibitor.
Compounds 1 and 2 inhibited heparinase in a dosedependent manner with the IC50 values of 3 /im and 10 /im, respectively. Suramin, known as a potent inhibitor of melanoma heparanase15) showed an IC50 value of 5^M in our assay system. Since there can be a possibility that the inhibitors mayaffect any other componentsemployedin the assay system (especially factor Xa, a serine protease), we examined the effect of the inhibitors on each components.
Wefound that 1 and 2 had no effects on the assay system, and only showed the inhibitory activity against heparinase itself.
To examine the antimetastatic capability of the compounds 1 and 2, an invasion assay of B16-F10 melanoma cells through laminin-coated matrigel was performed. Very hopefully, 1 (IC5O= 15/j,m) and 2 (IC50= 30/im) showed a strong inhibtion of B16-F10 cell migration. However, both the compounds showed negligible cytotoxicity against various cells up to 100jam (data not shown). Therefore, 1 and 2 would be new agents for the study of metastasis and angiogenesis, or possible candidates for anticancer therapeutics.
Thus, the detailed biological activities and in vivo experiments are now under investigation.
